Exudative vitreoretinopathy 4: genes and variants
Explore variant evidence for Exudative vitreoretinopathy 4 across 1 analyzed protein (LRP5). Linked ClinVar records include 17 pathogenic or likely pathogenic variants, 179 variants of uncertain significance and 28 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Exudative vitreoretinopathy 4
LRP5: Low-density lipoprotein receptor-related protein 5
It transduces canonical Wnt signals that strongly regulate bone formation and also contributes to retinal vascular development. Loss-of-function variants cause osteoporosis-pseudoglioma syndrome, while activating variants cause high-bone-mass disorders.
17 ClinVar pathogenic / likely pathogenic and 205 uncertain variants in LRP5 have source records linked to Exudative vitreoretinopathy 4. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): CTNNB1.
ClinVar pathogenic and likely pathogenic variants linked to Exudative vitreoretinopathy 4
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| LRP5 G404R | 404 | LDL-receptor class B 6 | Pathogenic / likely pathogenic (★★) |
| LRP5 D424N | 424 | LDL-receptor class B 6 | Pathogenic / likely pathogenic (★★) |
| LRP5 R494Q | 494 | LDL-receptor class B 8 | Pathogenic / likely pathogenic (★★) |
| LRP5 D1288G | 1288 | LDL-receptor class A 1 | Pathogenic / likely pathogenic (★★) |
| LRP5 T1041M | 1041 | LDL-receptor class B 17 | Pathogenic / likely pathogenic (★★) |
| LRP5 N198S | 198 | LDL-receptor class B 3 | Pathogenic / likely pathogenic (★★) |
| LRP5 R229W | 229 | LDL-receptor class B 4 | Pathogenic / likely pathogenic (★★) |
| LRP5 R1188W | 1188 | LDL-receptor class B 20 | Pathogenic / likely pathogenic (★★) |
| LRP5 D1363N | 1363 | LDL-receptor class A 3 | Pathogenic / likely pathogenic (★★) |
| LRP5 A422T | 422 | LDL-receptor class B 6 | Pathogenic / likely pathogenic (★) |
| LRP5 G876S | 876 | LDL-receptor class B 15 | Pathogenic / likely pathogenic (★) |
| LRP5 C926Y | 926 | EGF-like 3 | Pathogenic / likely pathogenic (★) |
| LRP5 C306Y | 306 | EGF-like 1 | Pathogenic / likely pathogenic (★) |
| LRP5 D862V | 862 | YWTD 11 | Pathogenic / likely pathogenic (★) |
| LRP5 P1026R | 1026 | LDL-receptor class B 16 | Pathogenic / likely pathogenic (★) |
| LRP5 L145F | 145 | LDL-receptor class B 2 | Pathogenic / likely pathogenic |
| LRP5 C1305Y | 1305 | LDL-receptor class A 2 | Pathogenic / likely pathogenic |
Uncertain variants prioritized for review in Exudative vitreoretinopathy 4
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| LRP5 C1305R | 1305 | LDL-receptor class A 2 | Uncertain (★★) | +7: C1305Y at the same position is pathogenic; seen in 2e-06 of gnomAD DNA copies; REVEL 0.987 |
Which prediction tools work for Exudative vitreoretinopathy 4
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- MetaLR: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 97 out of 100
- MutPred: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 96 out of 100
- CADD: 95 out of 100
- AlphaMissense: 94 out of 100
- phyloP: 81 out of 100
- Pangolin: 45 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SpliceAI: 32 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Osteoporosis with pseudoglioma also has ClinVar records linked to LRP5 variants; they fall mostly in different places as the Exudative vitreoretinopathy 4 variants (9 pathogenic / likely pathogenic).
- Worth disease also has ClinVar records linked to LRP5 variants; they fall mostly in different places as the Exudative vitreoretinopathy 4 variants (9 pathogenic / likely pathogenic).
- Autosomal dominant osteopetrosis also has ClinVar records linked to LRP5 variants; they fall mostly in different places as the Exudative vitreoretinopathy 4 variants (6 pathogenic / likely pathogenic).
Diseases related to Exudative vitreoretinopathy 4
- Osteogenesis imperfecta, also linked to LRP5
- Osteoporosis with pseudoglioma, also linked to LRP5
- Worth disease, also linked to LRP5
- Osteoporosis, also linked to LRP5
- Autosomal dominant osteopetrosis, also linked to LRP5
- Polycystic liver disease 4 with or without kidney cysts, also linked to LRP5
- Bone mineral density quantitative trait locus 1, also linked to LRP5
- Postmenopausal osteoporosis, also linked to LRP5
- Autosomal dominant polycystic liver disease, also linked to LRP5
- Skeletal dysplasia, also linked to LRP5
- Familial exudative vitreoretinopathy, also linked to LRP5
Frequently asked questions
Which genes have records linked to Exudative vitreoretinopathy 4?
This view contains 1 analyzed proteins: LRP5. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 17 pathogenic or likely pathogenic variants, 179 variants of uncertain significance and 28 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 1 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 234 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center